glp 1 mixing ratio Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison GLP-1 Genetics: How Genes Affect

Poster presented at the 68th scientific session of the American Diabetes Association, 6-10

For instance, the subcutaneously injected drug Semaglutide 2.4 mg, approved in 2021 and administered once a week, has been shown to achieve an average weight reduction of 15%-17% and also offers cardiovascular protective effects

Professional Guidance : If you're considering using a GLP-1 agonist while breastfeeding, its essential to discuss it with your healthcare provider

While they can help with weight loss, especially in people with obesity, their effectiveness is enhanced when used alongside lifestyle changes such as a healthy diet and regular physical activity